Machina Capital S.A.S. reduced its holdings in IDEX Corporation by 47.2% during the third quarter, selling 6,176 shares and retaining 6,895 shares at the end of the period. According to the firm’s latest Form 13F filing with the Securities and Exchange Commission, the remaining stake was valued at approximately 1.122 million. This sizable divestiture contrasts with the broader institutional ownership profile—97.96% of shares are held by institutional investors and hedge funds—and may signal shifting confidence among certain discretionary managers in IDEX’s near-term industrial end-market outlook.

Other major funds exhibited mixed activity: Empowered Funds LLC modestly increased its position by 3.4%, adding 54 shares for a total holding of 1,646 shares; Mirae Asset Global Investments boosted its stake by 8.9%, acquiring 971 additional shares to reach 11,901 shares; QRG Capital Management added 1,380 shares, a 13.6% increase; and DAVENPORT & Co LLC grew its position by 58.5%, purchasing 713 shares to hold 1,932 shares. On the sell-side, five brokerages maintain a buy or outperform stance, with lifted targets in the 200–220 range and an average consensus rating of Moderate Buy. Two firms retain hold assessments, reflecting cautious views on valuation given the company’s premium multiples.

In the fourth quarter, IDEX reported adjusted earnings per share of 2.10, beating consensus by 0.06 and representing a year-over-year increase of 2.9%. Revenue reached 899.1 million, up 4.2% versus the prior year on a combination of positive pricing and modest volume growth in health & science and metering segments, partially offset by softer machinery demand. Gross margin expanded by 60 basis points to 43.1%, driven by productivity initiatives and lower inventory step-up charges. Management set first-quarter EPS guidance at a range of 1.73 to 1.78 and full-year EPS guidance at 8.15 to 8.35, indicating expectations for low-single-digit organic sales growth and continued margin leverage from cost containment programs.